Fevipiprant, a prostaglandin D2 receptor 2 antagonist, in patients with persistent eosinophilic asthma: a single-centre, randomised, double-blind, parallel-group, placebo-controlle... by Gonem, S, Berair, R, Singapuri, A, Hartley, R, Laurencin, M, Bacher, G, Holzhauer, B, Bourne, M, Mistry, V, Pavord, I, Mansur, A, Wardlaw, A, Siddiqui, S, Kay, R, Brightling, C

Fevipiprant reduces airway smooth muscle mass in asthmatics via PGD2 receptor antagonism by Saunders, R, Kaul, H, Berair, R, Singapuri, A, Chernyavsky, I, Chachi, L, Biddle, M, Utcliffe, A, Laurencin, M, Bacher, G, Bourne, M, Pavord, I, Wardlaw, A, Siddiqui, S, Kay, R, Brook, B, Smallwood, R, Brightling, C

Fevipiprant reduced airway smooth muscle massin asthmatics via PGD2Receptor antagonism by Saunders, R, Sandrini, A, Kaul, H, Berair, R, Singapuri, A, Chernyavsky, I, Chachi, L, Biddle, M, Sutcliffe, A, Laurencin, M, Bacher, G, Bourne, M, Pavord, I, Wardlaw, A, Siddiqui, S, Kay, R, Brook, B, Smallwood, R, Brightling, C